{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:14:00Z","timestamp":1791994440232,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006087","name":"National Autonomous University of Mexico Directorate General of Academic Staff Affairs","doi-asserted-by":"publisher","award":["IN202217"],"award-info":[{"award-number":["IN202217"]}],"id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.yebeh.2024.110163","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T14:15:42Z","timestamp":1732889742000},"page":"110163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Central expression and peripheral levels of MMP-9 and TIMP-1 in patients with temporal lobe epilepsy"],"prefix":"10.1016","volume":"162","author":[{"given":"Andrea","family":"Toledo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Orozco-Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamile","family":"Paredes Chiquini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara I.","family":"Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris E.","family":"Mart\u00ednez Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Fleury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2024.110163_b0005","unstructured":"WHO, 2019. Epilepsy: A public health imperative, Geneva: World HealthOrganization, Licence: CC BY-NC-SA 3.0 IGO, ISBN 978-92-4-151593-1."},{"key":"10.1016\/j.yebeh.2024.110163_b0010","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.110163_b0015","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.110163_b0020","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.51.5.1256","article-title":"Is the underlying cause of epilepsy a major prognostic factor for recurrence?","volume":"51","author":"Semah","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2024.110163_b0025","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","article-title":"Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy","volume":"15","author":"Vezzani","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"10.1016\/j.yebeh.2024.110163_b0030","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41583-024-00805-1","article-title":"mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment","volume":"25","author":"Ravizza","year":"2024","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.yebeh.2024.110163_b0035","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/epi.16742","article-title":"Increased frequency of proinflammatory CD4 T cells and pathological levels of serum neurofilament light chain in adult drug-resistant epilepsy","volume":"62","author":"Ou\u00e9draogo","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.110163_b0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.seizure.2021.07.028","article-title":"Temporal lobe epilepsy: Evaluation of central and systemic immune-inflammatory features associated with drug resistance","volume":"91","author":"Toledo","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2024.110163_b0045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/10409230290771546","article-title":"Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)","volume":"37","author":"Van den Steen","year":"2002","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.yebeh.2024.110163_b0050","first-page":"105","article-title":"The significance of matrix metalloproteinases in parasitic infections involving the central nervous system","volume":"2","author":"Bruschi","year":"2013","journal-title":"Pathogens (Basel, Switzerland)"},{"key":"10.1016\/j.yebeh.2024.110163_b0055","doi-asserted-by":"crossref","first-page":"13376","DOI":"10.1038\/s41598-021-92881-x","article-title":"Structural characterization of inhibitory and non-inhibitory MMP-9-TIMP-1 complexes and implications for regulatory mechanisms of MMP-9","volume":"11","author":"Charzewski","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.yebeh.2024.110163_b0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.seizure.2023.02.012","article-title":"Changes in serum blood-brain barrier markers after bilateral tonic-clonic seizures","volume":"106","author":"Cudna","year":"2023","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2024.110163_b0065","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nri3499","article-title":"Metalloproteinases and their natural inhibitors in inflammation and immunity","volume":"13","author":"Khokha","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.yebeh.2024.110163_b0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00441-010-1025-1","article-title":"TIMP-1 interaction with \u03b1v\u03b23 integrin confers resistance to human osteosarcoma cell line MG-63 against TNF-a induced apoptosis","volume":"342","author":"Tsagaraki","year":"2010","journal-title":"Cell tissue Res"},{"key":"10.1016\/j.yebeh.2024.110163_b0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.tcb.2018.08.006","article-title":"Recognizing the Molecular Multifunctionality and Interactome of TIMP-1","volume":"29","author":"Gr\u00fcnwald","year":"2019","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.yebeh.2024.110163_b0080","article-title":"Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development","volume":"7369020","author":"Bronisz","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.yebeh.2024.110163_b0085","first-page":"749","article-title":"Increased Expression of Matrix Metalloproteinase-9 in Patients with Temporal Lobe Epilepsy","volume":"25","author":"Acar","year":"2015","journal-title":"Turk Neurosurg"},{"key":"10.1016\/j.yebeh.2024.110163_b0090","doi-asserted-by":"crossref","first-page":"1296876","DOI":"10.3389\/fnins.2024.1296876","article-title":"Meta-analysis of MMP-9 levels in the serum of patients with epilepsy","volume":"18","author":"Wang","year":"2024","journal-title":"Front Neurosci"},{"key":"10.1016\/j.yebeh.2024.110163_b0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eplepsyres.2016.11.006","article-title":"Serum metalloproteinase 9 levels increase after generalized tonic-clonic seizures","volume":"129","author":"Cudna","year":"2017","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2024.110163_b0100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.brainres.2013.09.044","article-title":"Increased metalloprotease activity in the epileptogenic lesion\u2013Lobectomy reduces metalloprotease activity and urokinase-type uPAR circulating levels","volume":"1538","author":"Quirico-Santos","year":"2013","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2024.110163_b0105","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.braindev.2021.08.003","article-title":"Serum matrix metallopeptidase-9 and tissue inhibitor of metalloproteinase-1 levels may predict response to adrenocorticotropic hormone therapy in patients with infantile spasms","volume":"44","author":"Matsuura","year":"2022","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2024.110163_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2023.01.004","article-title":"Biochemical mechanisms in pathogenesis of infantile epileptic spasm syndrome","volume":"105","author":"Riikonen","year":"2023","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2024.110163_b0115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.mehy.2010.09.013","article-title":"Matrix metalloproteinase-9 may be a potential therapeutic target in epilepsy","volume":"76","author":"Yin","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.yebeh.2024.110163_b0120","doi-asserted-by":"crossref","first-page":"e138332","DOI":"10.1172\/JCI138332","article-title":"The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects","volume":"131","author":"Broekaart","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yebeh.2024.110163_b0125","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1002\/epi4.12590","article-title":"Factors not considered in the study of drug-resistant epilepsy: Drug-resistant epilepsy: Assessment of neuroinflammation","volume":"7","author":"Campos-Bedolla","year":"2022","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2024.110163_b0130","doi-asserted-by":"crossref","first-page":"12689","DOI":"10.3390\/ijms241612689","article-title":"Neuroinflammatory Dysfunction of the Blood-Brain Barrier and Basement Membrane Dysplasia Play a Role in the Development of Drug-Resistant Epilepsy","volume":"24","author":"Zabrodskaya","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.yebeh.2024.110163_b0135","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1528-1167.2012.03637.x","article-title":"Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches","volume":"53","author":"Marchi","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.110163_b0140","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0271678X16655551","article-title":"Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers","volume":"36","author":"Rempe","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.yebeh.2024.110163_b0145","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/cells12030368","article-title":"Blood-Brain Barrier-Associated Proteins Are Elevated in Serum of Epilepsy Patients","volume":"12","author":"Bronisz","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.yebeh.2024.110163_b0150","doi-asserted-by":"crossref","first-page":"14712","DOI":"10.3390\/ijms232314712","article-title":"Serum Proteins Associated with Blood-Brain Barrier as Potential Biomarkers for Seizure Prediction","volume":"23","author":"Bronisz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.yebeh.2024.110163_b0155","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awl318","article-title":"Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy","volume":"130","author":"Van Vliet","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2024.110163_b0160","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.3390\/cells13181547","article-title":"The Effect of Tissue Inhibitor of Metalloproteinases on Scar Formation after Spinal Cord Injury","volume":"13","author":"Mishra","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.yebeh.2024.110163_b0165","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3390\/ijms22041744","article-title":"Time-Course Changes of Extracellular Matrix Encoding Genes Expression Level in the Spinal Cord Following Contusion Injury-A Data-Driven Approach","volume":"22","author":"Bighinati","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.yebeh.2024.110163_b0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eplepsyres.2012.09.018","article-title":"Matrix metalloproteinase-9 (MMP-9) in human intractable epilepsy caused by focal cortical dysplasia","volume":"104","author":"Konopka","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2024.110163_b0175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12974-023-02837-3","article-title":"Identification of TIMP1 as an inflammatory biomarker associated with temporal lobe epilepsy based on integrated bioinformatics and experimental analyses","volume":"20","author":"He","year":"2023","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.yebeh.2024.110163_b0180","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.anndiagpath.2017.05.009","article-title":"Chronic inflammation in refractory hippocampal sclerosis-related temporal lobe epilepsy","volume":"30","author":"Gales","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.yebeh.2024.110163_b0185","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/B978-0-12-823493-8.00021-3","article-title":"Semiology, EEG, and neuroimaging findings in temporal lobe epilepsies","volume":"187","author":"Frazzini","year":"2022","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.yebeh.2024.110163_b0190","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s43440-020-00208-w","article-title":"Pro-inflammatory cytokines, but not brain- and extracellular matrix-derived proteins, are increased in the plasma following electrically induced kindling of seizures","volume":"73","author":"Chmielewska","year":"2021","journal-title":"Pharmacol Rep"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024005456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024005456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T04:06:50Z","timestamp":1733717210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505024005456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":38,"alternative-id":["S1525505024005456"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.110163","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central expression and peripheral levels of MMP-9 and TIMP-1 in patients with temporal lobe epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.110163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110163"}}